Cullinan Therapeutics

About:

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Website: https://www.cullinanoncology.com/

Top Investors: Blue Owl, OrbiMed, Invus, The Baupost Group, Biotechnology Value Fund

Description:

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.